Bookmark

Add to MyYahoo RSS

Phase2 Technology News

News on Phase2 Technology (Ticker: CYTR) continually updated from thousands of sources around the net.

12 hrs ago | Business Wire

Zeldes & Haeggquist, LLP Continues Investigation of CytRx Corporation

CytRx is a pharmaceutical research and development company headquartered in Los Angeles, California. The investigation focuses on allegations that CytRx hired a promoter, The DreamTeam Group , to publish favorable articles about CytRx stock without disclosing to investors that the Company had paid The DreamTeam Group to promote the stock.

Comment?

Related Topix: Biotech, Medicine, CytRx, Healthcare Industry, August, CA

Fri Sep 05, 2014

Freshnews

CytRx Updates Presentation Time at Aegis 2014 Healthcare & Technology Conference

CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company's presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday, September 12th at 10:45am Pacific Time.

Comment?

Related Topix: Biotech, Medicine, CytRx, Healthcare Industry, Oncology, Doxorubicin (generic), Adriamycin, Doxil, Sarcoma, Health, Brain Cancer

Tue Sep 02, 2014

Freshnews

CytRx to Present at Upcoming Investor Conferences in New York City and Las Vegas

CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced that President and CEO Steven A. Kriegsman and Vice President of Business Development and Investor Relations David Haen will present at the following upcoming investor conferences: 16th Annual Rodman & Renshaw Healthcare Conference on ... (more)

Comment?

Related Topix: Biotech, Medicine, CytRx, Healthcare Industry, Oncology, Sarcoma, Health, Brain Cancer

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••